Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond.

Ciccocioppo R, Gehlert DR, Ryabinin A, Kaur S, Cippitelli A, Thorsell A, Lê AD, Hipskind PA, Hamdouchi C, Lu J, Hembre EJ, Cramer J, Song M, McKinzie D, Morin M, Economidou D, Stopponi S, Cannella N, Braconi S, Kallupi M, de Guglielmo G, Massi M, George DT, Gilman J, Hersh J, Tauscher JT, Hunt SP, Hommer D, Heilig M.

Alcohol. 2009 Nov;43(7):491-8. doi: 10.1016/j.alcohol.2009.08.003. Review.

2.

Neurobiological mechanisms contributing to alcohol-stress-anxiety interactions.

Silberman Y, Bajo M, Chappell AM, Christian DT, Cruz M, Diaz MR, Kash T, Lack AK, Messing RO, Siggins GR, Winder D, Roberto M, McCool BA, Weiner JL.

Alcohol. 2009 Nov;43(7):509-19. doi: 10.1016/j.alcohol.2009.01.002. Review.

4.

Alcoholism and neuropeptides: an update.

Cowen MS, Lawrence AJ.

CNS Neurol Disord Drug Targets. 2006 Apr;5(2):233-9. Review.

PMID:
16611096
5.

Young Investigator Award symposium.

Witkiewitz K, Holmes A, Ray LA, Murphy JG, Richardson HN, Chen YC, McDevitt-Murphy ME, Cruz MT, Roberto M.

Alcohol. 2009 Nov;43(7):499-508. doi: 10.1016/j.alcohol.2009.06.004.

PMID:
19913193
6.

Acute stress differentially affects corticotropin-releasing hormone mRNA expression in the central amygdala of the "depressed" flinders sensitive line and the control flinders resistant line rats.

Zambello E, Jiménez-Vasquez PA, El Khoury A, Mathé AA, Caberlotto L.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):651-61. Epub 2007 Nov 17.

PMID:
18077069
7.

Treatment of alcohol dependence with drug antagonists of the stress response.

Higley AE, Koob GF, Mason BJ.

Alcohol Res. 2012;34(4):516-21.

8.

Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD).

Rodriguez FD, Coveñas R.

Curr Med Chem. 2017;24(23):2528-2558. doi: 10.2174/0929867324666170316120836. Review.

PMID:
28302012
9.

Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior.

Ryabinin AE, Tsoory MM, Kozicz T, Thiele TE, Neufeld-Cohen A, Chen A, Lowery-Gionta EG, Giardino WJ, Kaur S.

Alcohol. 2012 Jun;46(4):349-57. doi: 10.1016/j.alcohol.2011.10.007. Epub 2012 Mar 22. Review.

10.

Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.

Walker BM, Valdez GR, McLaughlin JP, Bakalkin G.

Alcohol. 2012 Jun;46(4):359-70. doi: 10.1016/j.alcohol.2011.10.006. Epub 2012 Mar 27. Review.

11.

Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.

Heilig M, Egli M.

Pharmacol Ther. 2006 Sep;111(3):855-76. Epub 2006 Mar 20. Review.

PMID:
16545872
12.

Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.

Martin-Fardon R, Zorrilla EP, Ciccocioppo R, Weiss F.

Brain Res. 2010 Feb 16;1314:145-61. doi: 10.1016/j.brainres.2009.12.027. Epub 2009 Dec 21. Review.

13.

Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety.

Thorsell A.

Exp Biol Med (Maywood). 2010 Oct;235(10):1163-7. doi: 10.1258/ebm.2010.009331. Review.

PMID:
20881320
14.

The central amygdala and alcohol: role of γ-aminobutyric acid, glutamate, and neuropeptides.

Roberto M, Gilpin NW, Siggins GR.

Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a012195. doi: 10.1101/cshperspect.a012195. Review.

16.

Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.

Heilig M, Thorsell A, Sommer WH, Hansson AC, Ramchandani VA, George DT, Hommer D, Barr CS.

Neurosci Biobehav Rev. 2010 Nov;35(2):334-44. doi: 10.1016/j.neubiorev.2009.11.018. Epub 2009 Nov 24. Review.

17.

Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors.

Sillaber I, Rammes G, Zimmermann S, Mahal B, Zieglgänsberger W, Wurst W, Holsboer F, Spanagel R.

Science. 2002 May 3;296(5569):931-3.

18.
19.

Swim stress enhances nociceptin/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: role of corticotropin releasing factor.

Nazzaro C, Barbieri M, Varani K, Beani L, Valentino RJ, Siniscalchi A.

Neuropharmacology. 2010 Feb;58(2):457-64. doi: 10.1016/j.neuropharm.2009.09.004. Epub 2009 Sep 9.

20.

Supplemental Content

Support Center